March 16, 2008 – In a paper published online today in the journal Nature, a team of deCODE scientists detail a major mechanism through which genetic factors contribute to major public health problems. In its work on the inherited components of dozens of common diseases, deCODE has discovered gene variants that significantly affect individual susceptibility or protection against disease...
...In today’s paper, the deCODE team and collaborators from Merck demonstrate one of the principal ways in which the activity of biological pathways is functionally perturbed in a quintessentially complex condition: obesity. Through analysis of adipose tissue from some 1700 Icelandic participants in obesity research cohorts, the deCODE team showed in data derived from primary human tissue that variations in gene expression – in the up-regulation or downregulation of how genes are translated into proteins – have a major impact on several parameters of clinical obesity... deCODE 's Press Release -
Blog Archive
-
▼
2008
(55)
-
▼
March
(13)
- Sanofi-aventis : NICE Recommends Acomplia to be in...
- deCODE Obesity Genetics study merck
- Arena Pharmaceuticals' Lorcaserin for Obesity
- VIVUS, Enrollment in EQUATE (OB-301) Trial completed
- Thiakis, Novel therapy for treatment of obesity en...
- Alizyme's cetilistat,Phase III development program...
- Merck, Innovative Research Method to Identify Chan...
- Marcadia Biotech and Merck, strategic collaboration
- Hollis-Eden Pharmaceuticals, Positive Preliminary ...
- Bar Harbor BioTechnology : New Line of StellARrays
- EnteroMedics, Expansion of EMPOWER Pivotal Study f...
- OREXIGEN Therapeutics, European Patent Office Allo...
- Athersys, Results for Phase 1 Safety Study of Its ...
-
▼
March
(13)